A Clever Application

Medical News Today reports on a clever application of new knowledge and capabilities related to controlling cells: "We used the brain's own signaling molecules to guide the genetically modified monocytes along a concentration gradient to the degenerating brain cells ... We showed that improvement of the disease was directly related to the amount of genetically modified monocytes reaching the degenerating brain cells. The improvement was clearly linked to the ability of the corrected neurons to break down excess GM1 with the enzyme delivered by the monocytes." While this was not aimed at an age-related neurodegenerative disease, we can expect to see many more similarly clever therapies as the knowledge base grows.

Link: http://www.medicalnewstoday.com/medicalnews.php?newsid=26473